AN2 Therapeutics, Inc. (ANTX) Live Share Price, Invest From India

AN2 Therapeutics, Inc. Stock Performance

as on November 3, 2026 at 2:16 pm IST

Day's Low
Day's High
$4.24
Day's Price Range
$4.61
$4.35
2.53%
Downside
5.98%
Upside
52 Week's Low
52 Week's High
$1.00
52-Week Price Range
$7.19
$4.35
77.01%
Downside
65.29%
Upside

AN2 Therapeutics, Inc. share price movements today

Previous Close: $4.53
Open: $4.58
Volume: 328.2K
Market Cap: $170.9M
Day's Low - High: $4.24 - $4.61
52 Week Low - High: $1.00 - $7.19

AN2 Therapeutics, Inc. Historical Returns

1 Month Return: -20.67 %
3 Month Return: -15.33 %
1 Year Return: + 268.29 %
3 Year Return: -69.8 %
5 Year Return: 0 %

AN2 Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check AN2 Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$170.9M

EPS (TTM)

-1.07

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.23

Industry PE ratio

-3.03

PEG Ratio

-0.30

EBITDA

-37.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-53.52%

AN2 Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AN2 Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
AN2 Therapeutics, Inc.	Buy	$170.9M	NA	-4.23	0.00%	0.00%
Moderna	Neutral	$88.5B	-36.16%	-27.78	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$141.7B	192.56%	32.27	86.04%	0.00%
Regeneron	Buy	$95.5B	47.41%	19.76	85.77%	0.40%

Stock Returns calculator for AN2 Therapeutics, Inc. Stock including INR - Dollar returns

The AN2 Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

AN2 Therapeutics, Inc. investment value today

Current value as on today

₹3,78,279

Returns

₹2,78,279

(+278.28%)

Returns from AN2 Therapeutics, Inc. Stock

₹2,53,659 (+253.66%)

Dollar Impact

₹24,620 (+24.62%)

Analyst Recommendation on AN2 Therapeutics, Inc. Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for AN2 Therapeutics, Inc.. Average target price of $9

AN2 Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on AN2 Therapeutics, Inc..

What analysts predicted

51.67%UPSIDE

Target Price

Current Price

$4.35

Analyzed by

11 Analysts

Target

$9.00

AN2 Therapeutics, Inc. target price $9, a slight upside of 51.67% compared to current price of $4.35. According to 11 analysts rating.

Indian Investors' Interest in AN2 Therapeutics, Inc. Stock

Search interest for AN2 Therapeutics, Inc. Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 4, 2026 to November 3, 2026

Change:51% versus previous 30 day period

AN2 Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-18	-15	-14	-8	-11	-7	-10	-9	-10	-8
EBITDA	-16	1	-11	-	-10	-6	-9	-10	-10	-8
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	15	-	8	-	-	-	-	-	-
Income Before Tax	-16	-14	-12	-7	-10	-6	-9	-8	-10	-8
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-16	-14	-12	-7	-10	-6	-9	-8	-10	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

AN2 Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	-	-	-
Operating Income	-31	-7	-21	-42	-69	-54	-38
EBITDA	-	-6	-21	-40	4	3	-35
Interest Expense	-	-	-	0	-	-	-
Depreciation	31	7	-	0	69	54	-
Income Before Tax	-33	-13	-21	-40	-64	-51	-35
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-33	-13	-21	-40	-64	-51	-35
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

AN2 Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-16	-14	-12	-7	-10	-6	-9	-8	-10	-8
Operating Cash Flow	-17	-14	-12	-5	-10	-7	-6	-5	-12	-6
Investing Cash Flow	26	16	18	-6	9	5	6	7	8	-3
Financing Cash Flow	0	-	0	-	0	-	0	-	37	1
Change in Cash	9	2	6	-12	-1	-1	0	1	33	-9

AN2 Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-13	-21	-40	-64	-51	-35
Operating Cash Flow	-2	-5	-20	-33	-53	-49	-29
Investing Cash Flow	-	-	-50	-21	-43	54	28
Financing Cash Flow	8	3	78	70	84	0	0
Change in Cash	5	-1	8	15	-11	5	-1

Global Institutional Holdings in AN2 Therapeutics, Inc.

Check out the Institutions with significant holdings in AN2 Therapeutics, Inc..

Funds	Holdings
Kabeer Aziz	6.45%
Eric Easom	4.32%
Vanguard	3.69%
VANGUARD INDEX FUNDS	3.21%
iShares	2.61%

See all

Insights on AN2 Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, ANTX stock has moved up by 278.3%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 508.2%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 255.9%

About AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.

Organisation	AN2 Therapeutics, Inc.
Headquarters	1800 El Camino Real, Menlo Park, CA, 94025, US
Industry	Biotechnology
CEO	Eric E. Easom

Key Management of AN2 Therapeutics, Inc.

Name	Title
Ms. Lucy O. Day CPA	CFO, & Principal Financial Officer
Mr. Joshua M. Eizen J.D.	Chief Legal Officer, COO & Corporate Secretary
Dr. George Harrison Talbot FACP, M.D.	Co-Founder & Senior Clinical Advisor
Ms. Sarah Williams	Vice President of Controller & Principal Accounting Officer
Mr. Eric E. Easom	Co-Founder, CEO, President & Chairman of the Board
Mr. Joseph S. Zakrzewski	Co-Founder & Independent Director
Dr. Michael R. K. Alley Ph.D.	Co-founder & Head of Biology
Dr. Sanjay Chanda Ph.D.	Chief Development Officer
Mr. Vince Hernandez	Head of Research
Dr. Cameron Trenor M.D.	Chief Medical Officer

FAQs

What is AN2 Therapeutics, Inc. share price today?

AN2 Therapeutics, Inc. share price today is $4.35 as on November 3, 2026 at 8:46 am IST at the close of the market. AN2 Therapeutics, Inc. share today touched a day high of $4.61 and a low of $4.24.

What is the 52 week high and 52 week low for AN2 Therapeutics, Inc. share?

AN2 Therapeutics, Inc. share touched a 52 week high of $7.19 on August 12, 2026 and a 52 week low of $1.00 on February 19, 2026. AN2 Therapeutics, Inc. stock price today i.e. November 3, 2026 at 8:46 am IST is closed at $4.35,which is 39.50% down from its 52 week high and 335.00% up from its 52 week low.

What is AN2 Therapeutics, Inc.'s market capitalisation today?

AN2 Therapeutics, Inc. market capitalisation is $0.00T as on November 3, 2026 at 8:46 am IST.

How to invest in AN2 Therapeutics, Inc. Stock (ANTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for AN2 Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy AN2 Therapeutics, Inc. Stock (ANTX) from India?

Indian investors can start investing in AN2 Therapeutics, Inc. (ANTX) shares with as little as ₹94.9000015258789 or $1 (as of November 3, 2026 at 10:28 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in AN2 Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on November 3, 2026 at 10:28 am IST). Based on AN2 Therapeutics, Inc. share’s latest price of $4.35 as on November 3, 2026 at 8:46 am IST, you will get 2.2989 shares of AN2 Therapeutics, Inc.. Learn more about fractional shares .